The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Presenter: Mark Reisman

REGISTER for free or LOG IN to view this content

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Up Next

More slides +

We Recommend